**Table 1: Clinical Characteristics & FRAX Risk Assessment (Osteopenia Sub-cohort)**

| Parameter | Fracture (n=47) | Control (n=44) | % Diff | P-value | Cohen's d |
|:---|:---:|:---:|:---:|:---:|:---:|
| Age (years) | 59.51 ± 7.23 | 57.23 ± 8.87 | 4.0% | 0.184 | 0.28 |
| BMI (kg/m²) | 28.54 ± 4.40 | 28.39 ± 4.60 | 0.5% | 0.870 | 0.03 |
| L1-L4 T-score | -1.63 ± 0.76 | -1.36 ± 0.84 | 20.0% | 0.111 | 0.34 |
| Femoral Neck T-score | -1.34 ± 0.65 | -1.29 ± 0.57 | 3.7% | 0.712 | 0.08 |
| Trabecular Bone Score (TBS) | 1.25 ± 0.14 | 1.28 ± 0.08 | -2.3% | 0.208 | 0.26 |
| FRAX Major Fracture (%) | 4.59 ± 3.40 | 3.86 ± 3.14 | 18.9% | 0.290 | 0.22 |
| FRAX Hip Fracture (%) | 0.98 ± 1.08 | 0.85 ± 1.19 | 14.8% | 0.597 | 0.11 |

*Note: Neither FRAX, TBS, nor BMD significantly discriminated fracture status (p > 0.05).*
